HF-ACTION involved 2,331 heart failure patients (average age, 59 years) who were followed for about 2.5 years. ... Researchers tested whether irbesartan (Avapro) might lower death and hospitalizations for heart failure, myocardial infarction, stroke and
physicians provide optimal care to patients with heart failure and reduced ejection fraction. ... Achieving optimal therapy given multiple drugs for heart failure;. Timing of referral to a heart failure specialist;.
of drugs that should be avoided or used with caution in patients with heart failure. ... Abraham said. Minoxidil, a vasodilator, can worsen clinical outcomes in patients with heart failure.
and EMPEROR-Reduced (EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction). ... The updated pathway should serve as interim guidance to clinicians while awaiting the comprehensive and definitive heart failure
clinical markers considered for adjustment of heart failure medication, and one of four medication classes used for usual care was displayed. ... This low-cost intervention can be rapidly integrated into clinical care and accelerate adoption of
Research indicates that risk for heart failure in patients with diabetes increases with HbA1c level, Dr. ... should we be using, then, for the management of diabetes in the setting of heart failure?”.
need for intensified diuretics as an indicator of worsening heart failure, the authors said. ... blocker and beta-blocker within 120 days, and had not been hospitalized for heart failure since diagnosis.
Instead, they should describe those patients as having “heart failure in remission,” she said. ... To identify worsening heart failure, physicians can ask a patient two key questions, Dr.
Mean follow-up was 3.5 years. Overall, there were 489 first heart failure events and 1,078 recurrent heart failure events. ... to [heart failure], when compared to patients who were receiving warfarin,” the authors wrote.
Heart failure is associated with neurocognitive dysfunction and decline independent of other comorbidities, a study found. ... impairment (relative risk ratio, 1.36; 95% CI, 1.12 to 1.64) than those without heart failure.